Is the new Congress ready to lower drug costs?

If you haven’t already, don’t forget to register for our upcoming webinar, “Is the new Congress ready to lower drug costs?”

STAT Washington correspondents Nicholas Florko and Lev Facher will assess the political landscape in Washington D.C. and discuss the potential roadblocks the new Congress may face in their efforts to lower drug costs.

Register Now


UPDATE:
This webinar was originally scheduled for Feb. 26. It has been moved to Feb. 27, so that our reporters can discuss the latest news from the Feb. 26 Senate Finance Committee hearing with seven major drug company CEOs.